New Pan-European Digital Pathology Network Aims to Transform Diagnosis and Treatment of Cancer and Other Diseases

• A new digital pathology solution allows pathologists to examine tissues in high-resolution on their computer screens from any network location and easily get second opinions
• Previously pathologists would have to assess physical slides under a microscope and post them by mail for a second opinion. This could result in delays and risk slides being lost or damaged

22 June 2015 – Diagnosis and treatment of some of the most serious diseases have the potential to become faster and more accurate following the implementation of a new integrated pathology system by Labco Quality Diagnostics, a pan-European leader in pathology laboratory services. Developed by Omnyx, LLC, a joint venture of GE Healthcare and UPMC (University of Pittsburgh Medical Center), the system will allow Labco pathologists to work more efficiently, viewing digitized images of human tissue in high-resolution on their computer screens from any location with an internet connection.

Previously pathologists would have to assess physical slides under a microscope and post them by mail for a second opinion. This could result in delays, risks slides being lost or damaged and hindered collaboration efforts. It could also delay the prescription of the most appropriate course of care for patients.

Dr. José Antonio López García Asenjo, Director of Pathology Diagnostics Quality at Labco explains: “With this collaboration, Labco is leading the transformation of pathology in Europe. We are breaking away from the limitations of traditional methods of analysing samples, aiming to offer faster, more skilled and more reliable diagnoses. Ultimately, we believe that the collaboration between Labco and GE Healthcare will help bring a significant improvement in the quality and safety of diagnostics in pathology.”

The digital pathology network’s central hub will be based in Labco’s laboratories in Madrid, Spain. It will initially connect a network of approximately 50 pathologists in Spain and 15 in the UK, all of whom are highly specialized in their respective clinical fields. There are also plans to extend to more laboratories across Europe. This will connect pathologists from Labco’s pan-European network that provides services to over 25 million patients annually through over 160 laboratories and 150 clinics in France, Switzerland, Belgium, Italy, Spain, Portugal and the United Kingdom.

Read more here: http://www.omnyx.com/news-events/new-pan-european-digital-pathology-network-aims-to-transform-diagnosis-and-treatment-of-cancer-and-other-diseases/

Source: Omnyx, LLC